Recommendation ID
IPG469/1
Question
NICE encourages further research into microwave ablation for treating primary lung cancer and metastases in the lung. Research studies should report details of patient selection and adverse events. Outcomes should include local tumour control, survival and quality of life.
Any explanatory notes
(if applicable)
There is evidence from imaging studies for the efficacy of microwave ablation for treating primary lung cancer and metastases in the lung, but evidence that the procedure improves clinical outcomes and quality of life is limited in quantity and quality. There is a risk of complications, including pneumothorax, which may have serious implications for patients with already compromised lung function. Therefore this procedure should only be used with special arrangements for clinical governance, consent and audit.

Source guidance details

Comes from guidance
Microwave ablation for treating primary lung cancer and metastases in the lung
Number
IPG469
Date issued
November 2013

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 19/12/2013